Infantile bilateral striatal necrosis is a rare brain disorder that usually begins in infancy or early childhood. Early signs of Infantile bilateral striatal necrosis can include loss of motor skills, muscle stiffness, abnormal movements, trouble speaking or swallowing, and seizures. The condition is often long-lasting and progressive, so symptoms may worsen over time, although not everyone will have the same experience. Infantile bilateral striatal necrosis can be life-threatening in severe cases, especially when breathing, swallowing, or repeated infections become major problems. Treatment does not cure Infantile bilateral striatal necrosis, but many living with it may receive supportive care such as seizure medicines, physical therapy, nutrition support, and treatment of the underlying cause when one is found.
How many people live with Infantile bilateral striatal necrosis?
Infantile bilateral striatal necrosis is so rare that no reliable worldwide count is consistently reported; major rare disease sources describe it as extremely rare or do not give a direct number of people living with it (Orphanet, 2024). The same is true in the United States, where no recent, source-backed estimate has been consistently published for how many people are living with this condition (Genetic and Rare Diseases Information Center, 2024).
Overview
Infantile bilateral striatal necrosisSymptoms
Infantile bilateral striatal necrosis often starts in infancy or early childhood with developmental slowing or loss of skills. Many children develop movement problems such as stiffness, twisting, poor balance, or trouble speaking and swallowing. Seizures can happen.
Outlook and prognosis
Infantile bilateral striatal necrosis usually causes lasting movement and developmental problems, and many children need ongoing therapies and daily support. Outlook varies, but early symptoms of Infantile bilateral striatal necrosis often signal a serious condition that can worsen over time.
Causes and risk factors
Infantile bilateral striatal necrosis is usually caused by a gene change, often inherited from both parents or arising new in the child. Risk is highest with a family history. Illnesses, fever, or metabolic stress can sometimes worsen how severely it appears.
Genetic influences
Genetics are very important in infantile bilateral striatal necrosis, because harmful gene changes can be a main cause in many cases. Different genetic variations can affect severity, age at onset, and whether other body systems are involved.
Diagnosis
Diagnosis of infantile bilateral striatal necrosis starts with symptoms and clinical features. Brain MRI usually shows typical changes in the deep brain areas. Genetic tests may confirm the diagnosis of infantile bilateral striatal necrosis.
Treatment and drugs
Treatment for infantile bilateral striatal necrosis focuses on easing symptoms, supporting movement, feeding, and breathing, and treating complications such as seizures. Many children also need physical, occupational, and speech therapy, with care guided by a neurology team.
Symptoms
In infants and young children with infantile bilateral striatal necrosis, the first noticeable changes often involve movement, feeding, and development rather than pain. Early on, this might look like a child who becomes unusually stiff, loses skills they had started to learn, or struggles more with swallowing. The early features of infantile bilateral striatal necrosis can differ by cause, but many living with it have problems with muscle tone, movement control, and everyday skills.
Some children with infantile bilateral striatal necrosis stop gaining milestones or lose abilities they had already begun to develop, such as sitting, crawling, speaking, or using their hands. This can make play, feeding, and moving around much harder in daily life.
Muscles may become very stiff, rigid, or hard to relax, while some children seem unusually floppy instead. These changes can affect head control, posture, comfort, and how easily a child can be dressed or carried.
Many people with infantile bilateral striatal necrosis have twisting, jerky, shaking, or writhing movements that they cannot control. These movements can interfere with reaching, holding objects, standing, or staying steady in a chair.
Children who can stand or walk may become unsteady, drag a foot, or have trouble starting steps. Falls can become more common, and some may need extra support or mobility aids.
How people usually first notice Infantile bilateral striatal necrosis?
How infantile bilateral striatal necrosis is first noticed often begins with a baby or young child who suddenly stops meeting expected movement milestones or loses skills they had already started to gain, especially after a fever, infection, or another illness. Families and doctors may first notice unusual stiffness or floppiness, trouble feeding, abnormal eye movements, or new movement problems such as tremor, twisting, or difficulty controlling the arms and legs. For many living with infantile bilateral striatal necrosis, the first signs can look like a rapid change in movement and development, which is why urgent medical evaluation is important.
Types of Infantile bilateral striatal necrosis
No distinct types of Infantile bilateral striatal necrosis are widely recognized.
Can I slow down the onset of symptoms?
For infantile bilateral striatal necrosis, there is no proven lifestyle change or standard medical treatment that has been shown to reliably delay when symptoms start. Because this is a rare condition with several possible causes, early care with a child brain doctor and genetics team may sometimes help find a treatable underlying problem and quickly manage triggers like infections or other illness, but that may lower the chance of worsening in some children and does not mean the condition can be prevented. Research is still ongoing, so the most helpful step is early evaluation and close follow-up, while being honest that no approach is known to stop symptoms from beginning.
What genetics can tell you about symptoms
Genetics can sometimes explain why infantile bilateral striatal necrosis looks different from one child to another, including which movement, muscle tone, swallowing, or developmental problems show up first and how quickly they worsen. Changes in different genes can be linked to different patterns of symptoms, age at onset, and severity, although even children with changes in the same gene may not have exactly the same course. Genetic testing can help clarify the likely cause and may give families a better sense of what features doctors will watch for, but it usually cannot predict every symptom with certainty.
Causes and risk factors
Infantile bilateral striatal necrosis usually happens when the deep brain areas that control movement are damaged early in life. In many children with infantile bilateral striatal necrosis, the main cause is a gene change that affects how brain cells make and use energy, and this change may be inherited or new. Severe infections, high fevers, low oxygen around birth, or other body stresses can sometimes trigger or worsen the damage, especially in children who already have a genetic tendency. Family history can be one part of the story, but illnesses and other biological stresses add their own chapters. Everyday lifestyle habits are not usually the cause, but good prenatal care and quick treatment for serious illness may help reduce avoidable stress on the brain.
What are the most common causes or risk factors?
Infantile bilateral striatal necrosis is most often linked to inherited gene changes that interfere with how certain deep parts of the brain make and use energy, so family history and parents who both carry the same rare changed gene can raise the risk. In some children, it can also appear after a major stress on the body, such as a serious infection, high fever, lack of oxygen, or another problem with how the body handles energy. There is usually no lifestyle cause, and sometimes no clear trigger is found.
Environmental and biological risk factors
Infantile bilateral striatal necrosis is rare, and the risk factors for infantile bilateral striatal necrosis usually involve a major stress on the brain rather than anything a family did or did not do. Doctors often group risks into internal (biological) and external (environmental). In practice, the biggest concerns are problems that reduce oxygen or energy supply to the brain, serious infections or inflammation, and certain toxic exposures.
Some babies have body chemistry problems that make brain cells struggle to produce or use energy. Fever, vomiting, poor feeding, or another acute illness can turn that vulnerability into a metabolic crisis.
Any event that sharply reduces oxygen or blood flow to the brain, including severe birth complications, breathing failure, shock, or cardiac arrest, can injure the striatum. This is one of the best-recognized biological settings linked with infantile bilateral striatal necrosis.
Very low blood sugar, high acid levels in the blood, or a dangerous rise in ammonia can damage sensitive deep brain tissue. These problems may appear during severe infection, dehydration, or liver-related illness.
Viral or other serious infections can inflame the brain directly or place a heavy energy demand on it. In some children, this kind of illness is followed by infantile bilateral striatal necrosis.
Genetic risk factors
Infantile bilateral striatal necrosis is most often linked to rare gene changes that affect how vulnerable brain cells make energy or use key nutrients. Some risk factors are inherited through our genes. Understanding the genetic causes of infantile bilateral striatal necrosis can help families make sense of testing results and the chance of it happening again. More than one gene can be involved, so the exact genetic cause can differ from one child or family to another.
SLC19A3 changes: One of the best-known genetic causes of infantile bilateral striatal necrosis is a change in the SLC19A3 gene. This gene helps cells use thiamine, and when it does not work well, the striatum can be especially vulnerable.
Energy genes: Some cases are linked to gene changes that disrupt mitochondria, the parts of cells that make energy. This matters because the deep brain structures affected in infantile bilateral striatal necrosis need a steady energy supply to work normally.
Recessive inheritance: Many genetic forms follow a recessive pattern, which means a child inherits one changed copy of a gene from each parent. Parents are often healthy carriers and may not know they carry the change.
Mitochondrial DNA: A smaller number of cases involve changes in mitochondrial DNA, which is passed down from the mother. Symptoms and severity can vary a lot even among relatives with the same mitochondrial change.
Family history: Having a brother or sister with infantile bilateral striatal necrosis raises the chance that the same inherited gene change is present in the family. This is often one reason doctors suggest genetic testing for parents and sometimes siblings.
Shared ancestry: When biological parents are related, they are more likely to carry the same rare recessive gene change. That can increase the chance of this condition in a child, although infantile bilateral striatal necrosis remains very rare overall.
New variants: Rarely, the genetic change happens for the first time in a child instead of being passed down through the family. When this happens, the chance of it happening again in future children may be different, depending on the exact gene involved.
Lifestyle risk factors
Infantile bilateral striatal necrosis is not caused by lifestyle habits, but daily routines can still influence symptoms, comfort, and complications. In practice, how lifestyle affects infantile bilateral striatal necrosis is mostly through nutrition, movement, sleep, and illness-related stress on a vulnerable brain and body. Because feeding problems, dystonia, weakness, and developmental difficulties are common, caregiver-guided habits matter more than personal choice.
Poor intake, dehydration, or unsafe swallowing can worsen weakness, irritability, and recovery from illness in a child with infantile bilateral striatal necrosis. Careful feeding routines and texture adjustments may help maintain energy and reduce aspiration risk.
Inadequate calories or protein can make it harder to preserve growth, muscle strength, and day-to-day function when movement is already limited. Regular, balanced nutrition may support resilience during periods of neurological stress or regression.
Gentle physical therapy, stretching, and supported movement may help limit contractures, maintain joint range, and improve comfort in children with dystonia or rigidity. Long periods of immobility can worsen stiffness and reduce functional ability.
Irregular or poor-quality sleep can intensify fatigue, irritability, and motor instability in neurologically fragile children. A predictable sleep schedule may help daytime alertness and reduce stress on the child and caregivers.
Risk prevention
For infantile bilateral striatal necrosis, true prevention of the condition itself is usually not possible because it is often linked to underlying genetic or metabolic problems. In practice, prevention means lowering the chance of complications, avoiding stressors that can trigger worsening, and getting treatment quickly when changes appear. Some children may be stable for a time, then lose skills after a fever or other illness, so day-to-day prevention focuses on protecting the brain during these high-risk periods. Prevention is flexible because it needs to fit the child’s cause, symptoms, and overall health.
Fast treatment of fever, dehydration, breathing problems, or poor feeding can help reduce stress on the brain. If you notice early symptoms of infantile bilateral striatal necrosis, such as new stiffness, unusual movements, or loss of skills, urgent medical review matters.
Vaccines, handwashing, and avoiding close contact with people who are ill can lower the chance of infections that may trigger decline. For many living with infantile bilateral striatal necrosis, preventing common infections is one of the most practical protective steps.
Regular feeding and good hydration help prevent low blood sugar, dehydration, and physical stress, which can worsen symptoms in some children. Some may need a feeding plan, supplements, or tube feeding to stay well nourished.
If infantile bilateral striatal necrosis is linked to a metabolic disorder, following the prescribed diet and medicines closely can reduce the risk of crises. This may include avoiding fasting and having a sick-day plan for times of vomiting or poor intake.
Can you prevent Infantile bilateral striatal necrosis?
Usually, no, Infantile bilateral striatal necrosis cannot be fully prevented because it is often linked to inherited gene changes or other rare causes that are outside anyone's control. If this condition has happened in a family, talking with a genetics specialist can help parents understand the chance of it happening again, and getting prompt care for serious infections or major illness may help in some cases, but there is no proven way to reliably prevent it.
Transmission
Infantile bilateral striatal necrosis is not contagious, so it does not spread from one child to another through the air, close contact, food, or body fluids. For many families, the real question is how infantile bilateral striatal necrosis is inherited, because some cases are linked to gene changes that affect how the brain handles energy.
The pattern can vary with the underlying cause, but some forms are passed down when both parents carry a changed gene and a child inherits both copies, while others may result from a new gene change or, more rarely, a change passed through the mother’s mitochondrial DNA. Because the genetic transmission of infantile bilateral striatal necrosis is not the same in every family, genetic counseling is often the best way to understand the chance of it happening again.
When to test your genes
Genetic testing is most helpful as soon as infantile bilateral striatal necrosis is suspected, especially in a child with developmental regression, new movement problems, or MRI changes in the basal ganglia. It is also important when a sibling or close relative has had a similar childhood neurologic illness, because results can confirm the cause, guide care, and clarify recurrence risk.
Diagnosis
In infantile bilateral striatal necrosis, the first signs often show up in daily life, such as a baby losing skills, developing unusual stiffness, or having trouble with movement, swallowing, or speech. Doctors usually diagnose it by combining the child’s symptoms and exam findings with brain imaging and tests that look for an underlying cause. Because several genetic, metabolic, and sometimes infectious problems can lead to this pattern, the diagnosis of infantile bilateral striatal necrosis often takes more than one step.
Doctors ask about development, feeding, movement changes, and whether any skills have been lost over time. A detailed family and health history can help show whether the pattern suggests a genetic or metabolic condition.
The exam looks for changes such as muscle stiffness, unusual postures, weak muscle tone, or involuntary movements. These clinical features help show which parts of the nervous system may be affected.
MRI is usually the key imaging test because it can show characteristic changes in the striatum, a deep part of the brain involved in movement control. Symmetric abnormalities on both sides strongly support the diagnosis when they match the child’s symptoms.
Blood, urine, and sometimes spinal fluid tests may be used to look for metabolic disorders, mitochondrial disease, inflammation, or signs of infection. Tests may feel repetitive, but each one helps rule out different causes.
How is Infantile bilateral striatal necrosis diagnosed?
Infantile bilateral striatal necrosis is usually diagnosed by putting together a child’s symptoms and exam findings, especially new movement problems, stiffness, or loss of skills, with a brain scan called an MRI that shows damage in the same deep brain areas on both sides. Doctors also use blood and urine tests, and sometimes a sample of spinal fluid, to look for other possible causes such as infections or problems with how the body makes energy. Genetic testing can help confirm the cause in some children and show whether it may run in the family, but it is usually only one part of the full diagnosis.
Stages of Infantile bilateral striatal necrosis
Infantile bilateral striatal necrosis does not have defined progression stages. This is because it is usually identified by a pattern of symptoms and brain changes on scans, rather than by a set step-by-step decline that everyone moves through in the same way. Doctors usually start with a conversation about the early symptoms of infantile bilateral striatal necrosis, such as movement changes, loss of skills, stiffness, or trouble with speech or swallowing, and then combine this with a physical exam. Brain MRI is often central to diagnosis, and follow-up focuses on tracking symptoms, development, and any new movement or feeding problems over time.
Outlook and prognosis
The outlook for infantile bilateral striatal necrosis is usually guarded, because many affected children develop progressive movement problems, loss of previously acquired skills, and severe neurologic disability over time. Prognosis varies with the underlying cause, age at onset, and how quickly symptoms progress, but early-onset cases are often associated with a more severe course. Some children remain profoundly impaired with dystonia, feeding difficulties, speech limitation, and dependence on supportive care, while others may have slower progression or periods of relative stability. There is no cure, so treatment is mainly supportive and focused on nutrition, mobility, seizure control when present, and management of complications. Mortality can be increased, particularly in severe forms complicated by respiratory infections, aspiration, malnutrition, or other systemic problems, although exact survival estimates are not well defined because the condition is rare and genetically diverse.
Long-term effects
Infantile bilateral striatal necrosis often has lasting effects on movement, communication, and development, and the outlook can vary a lot from one child to another. Some children have a slow decline, while others are left with stable but significant disabilities after the early illness. Long-term effects vary widely, depending on the cause, how severe the brain injury is, and whether problems such as seizures or swallowing difficulty develop.
Many living with infantile bilateral striatal necrosis have ongoing stiffness, twisting movements, slowness, or poor balance. For many, this can mean trouble sitting, walking, using their hands, or keeping up with daily activities as they grow.
Speech can remain limited or become harder to understand over time because the brain areas that help control movement also affect the muscles used for talking. Some children understand more than they can express, while others have broader language delays.
Eating and drinking may stay difficult, with coughing, choking, or long mealtimes becoming an ongoing problem. This can raise the risk of poor weight gain, dehydration, or food going into the airway and causing chest infections.
Infantile bilateral striatal necrosis can lead to lasting delays in motor skills, learning, and everyday independence. Children who had severe early symptoms of infantile bilateral striatal necrosis are more likely to need lifelong support with mobility, communication, or self-care.
How is it to live with Infantile bilateral striatal necrosis?
Living with infantile bilateral striatal necrosis can mean coping with major changes in movement, muscle tone, speech, swallowing, and development, often beginning in infancy or early childhood. Many children living with this condition need help with feeding, mobility, communication, and daily routines, and some may have periods when skills are lost or symptoms worsen after illness. For families and other caregivers, daily life often becomes more structured and demanding, with frequent medical visits, therapy, hands-on care, and emotional stress, but supportive therapies and coordinated care can still help many children stay as comfortable, engaged, and connected as possible.
Treatment and drugs
Treatment for infantile bilateral striatal necrosis focuses on easing symptoms, supporting movement and daily function, and treating any underlying cause when one can be found. Because this condition affects deep parts of the brain that help control movement, many living with infantile bilateral striatal necrosis may need a mix of medicines for stiffness, abnormal movements, seizures, or pain, along with physical, occupational, and speech therapy. Treatment plans often combine several approaches. In some children, doctors may also use vitamins or other targeted treatments if testing shows a specific metabolic or genetic problem, but there is no single standard drug that reverses the brain injury itself. Not every treatment works the same way for every person, so care is usually individualized and may change over time as symptoms and needs change.
Can you cure Infantile bilateral striatal necrosis?
No, there is no cure for infantile bilateral striatal necrosis at this time. Treatment is aimed at managing symptoms and giving support, which can include help with seizures, movement problems, feeding, breathing, and therapies to support daily skills and communication. If doctors find an underlying cause that can be treated, they may address that too, but the damage in the brain usually cannot be undone.
Non-drug treatment
Daily care for Infantile bilateral striatal necrosis usually centers on helping a child move, eat, breathe, communicate, and stay as comfortable as possible. Because this condition can affect the brain areas that control movement, many living with Infantile bilateral striatal necrosis need ongoing therapy and practical support rather than one single treatment. Managing this condition often means combining rehab, feeding support, and symptom-focused care, with the plan adjusted as needs change over time.
Physical therapy can help with stiffness, twisting movements, poor balance, and loss of motor skills. Gentle stretching, guided exercises, and positioning work may support comfort, joint movement, and safer transfers.
Occupational therapy focuses on everyday tasks like sitting, reaching, hand use, bathing, and dressing. Some strategies can slip naturally into your routine—like seating changes or adaptive utensils—to make daily care easier and safer.
Speech and language therapy may help with communication and with swallowing problems that can happen in Infantile bilateral striatal necrosis. For some families, this becomes especially important when early symptoms of Infantile bilateral striatal necrosis include trouble feeding, coughing with meals, or a weaker cry.
Nutrition support may include texture changes, high-calorie meal plans, and guidance from a dietitian to help maintain growth. If swallowing is unsafe or eating takes too much effort, tube feeding may be discussed to lower the risk of choking and dehydration.
Your genes may have an impact on how drugs work for you
For infantile bilateral striatal necrosis, there is no well-established evidence that a person’s genes can reliably predict how they will respond to the medicines often used to ease symptoms like seizures, muscle stiffness, or movement problems. In daily life, this means two children with the same condition may still do better on different medicines or doses, so treatment is usually adjusted based on what helps most and what side effects show up. Because this condition can have different underlying causes, the care team often focuses more on careful symptom tracking and follow-up than on gene-based drug matching.
Pharmacological treatments
In infantile bilateral striatal necrosis, there is no single medicine that works for everyone because treatment depends on the cause and the symptoms a child is having. Drug treatment for infantile bilateral striatal necrosis often focuses on seizures, muscle stiffness or twisting, feeding-related discomfort, and any treatable metabolic problem found on testing. Not everyone responds to the same medication in the same way, so medicines are usually tailored and adjusted over time.
Antiseizure drugs such as levetiracetam, valproate, clobazam, or phenobarbital may be used if infantile bilateral striatal necrosis causes seizures. The choice depends on seizure type, age, and other health issues, and doses are adjusted carefully.
Baclofen, trihexyphenidyl, diazepam, or clonazepam may help reduce stiffness, painful muscle spasms, or twisting movements. For many living with infantile bilateral striatal necrosis, this can mean easier positioning, dressing, and daily care.
Levodopa, sometimes paired with carbidopa, may be tried when symptoms include slowness, rigidity, or other movement features linked to the basal ganglia. It does not help every child, but some may show meaningful improvement and are monitored closely for side effects.
In selected inherited or metabolic forms, doctors may prescribe thiamine and biotin because some children improve when these are started early. This is especially important when testing suggests a treatable disorder rather than using vitamins routinely for every case.
Genetic influences
Infantile bilateral striatal necrosis can be linked to inherited gene changes, especially ones that affect how brain cells handle energy or use vitamin B1. A well-known example is a change in SLC19A3, a gene that helps move this vitamin into cells, although other genes can lead to a similar pattern of injury in the same parts of the brain. Family history is one of the strongest clues to a genetic influence. In some families, the condition is passed down in an autosomal recessive way, meaning a child inherits one altered copy of the gene from each parent, while the parents are usually healthy carriers. More rarely, genes in mitochondria, the parts of cells that make energy, may be involved and can change how the condition is inherited. When specialists look for the genetic causes of infantile bilateral striatal necrosis, they often test more than one gene, which can help clarify the cause and the chance of it happening again in a future pregnancy, although some families still do not get a clear answer from testing.
Is Infantile bilateral striatal necrosis genetic?
Genetics are very important in infantile bilateral striatal necrosis, because harmful gene changes can be a main cause in many cases. Different genetic variations can affect severity, age at onset, and whether other body systems are involved.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families living with infantile bilateral striatal necrosis, one of the biggest questions is whether finding the genetic cause will change treatment. Often it can, because infantile bilateral striatal necrosis is not one single disorder with one standard medicine; the gene change may point doctors toward treatments that are more likely to help, or show that care will focus more on symptom control and support. In some children, especially when the condition is linked to a problem transporting thiamine into cells, early treatment with high-dose thiamine and sometimes biotin may help limit further injury and improve day-to-day function. In others, treatment is mainly supportive, such as medicines for seizures or abnormal movements, physical therapy, and careful care during infections or other stress on the body, because the underlying gene change may affect how brain cells work rather than a pathway with a specific targeted drug. Not every difference in response is genetic, but genetic testing can help doctors choose safer treatments, avoid less useful ones, and give families a clearer idea of what to expect over time. Because early symptoms of infantile bilateral striatal necrosis can look like other neurologic conditions, getting the genetic diagnosis as early as possible may make the biggest difference.
Interactions with other conditions
Infantile bilateral striatal necrosis often does not occur in isolation, and many living with this condition also have another underlying neurologic or metabolic disorder that affects how symptoms appear. In practice, it can overlap with mitochondrial disease, certain vitamin or energy-use disorders, and some inherited conditions that affect the brain’s deep movement-control areas, so weakness, stiffness, swallowing trouble, or developmental slowing may be harder to sort out. Some children also develop seizures, and illnesses such as fever, viral infections, or dehydration can sometimes trigger a sudden decline or make movement and feeding problems more noticeable. Doctors call it a “comorbidity” when two conditions occur together. This matters because the early symptoms of infantile bilateral striatal necrosis can look similar to cerebral palsy, encephalitis, or other causes of regression, which may delay finding the true cause. For families, this can mean that care often involves both neurology and genetics, and treatment plans may need to account for the underlying disease as well as day-to-day complications such as poor nutrition, breathing problems, or repeated infections.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Infantile bilateral striatal necrosis?
Doctors may first think about other causes of a child losing skills or developing stiffness, unusual twisting movements, trouble walking, or seizures, such as cerebral palsy, brain injury from low oxygen around birth, or a serious brain infection or inflammation. Some inherited conditions can look very similar too, especially disorders that affect how the body makes energy, such as Leigh syndrome, as well as other rare conditions that damage the brain areas that help control movement. Because the symptoms can overlap so much, doctors often need brain scans, blood tests, and genetic testing to tell them apart.
History
Throughout history, doctors have described children who seemed to lose skills after a period of typical early development, then developed movement problems such as stiffness, twisting, or trouble swallowing. What we now call infantile bilateral striatal necrosis was not recognized all at once. Early reports were based on what families and doctors could see day to day, and on changes found in deep parts of the brain after death, especially in the areas that help control movement.
As brain imaging and lab testing improved in the late 20th century, infantile bilateral striatal necrosis became easier to identify during life rather than only afterward. In recent decades, awareness has grown, and researchers learned that this pattern of brain injury can appear in more than one setting rather than being a single, simple disorder. Some children became ill after an infection or other stress on the body, while others had a pattern that suggested an underlying genetic cause. That helped explain why the early symptoms of infantile bilateral striatal necrosis can look similar from one child to another, even when the reason behind it is not exactly the same.
Over time, doctors also became better at separating infantile bilateral striatal necrosis from other conditions that can affect movement, muscle tone, and development in babies and young children. This mattered for families, because an episode that first looks like "just" delayed milestones or unusual stiffness may turn out to reflect a specific disease process in the brain. Today, the history of infantile bilateral striatal necrosis is still evolving, but the main shift has been clear: from scattered case descriptions to a better understanding that careful imaging, clinical follow-up, and broader research can help clarify diagnosis, guide care, and support families living with this rare condition.